Biotech | May 12, 2022
Mawi DNA Technologies launches NextSWAB for Covid-19 test results
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
RNA extraction free kit to deliver results in just 45 minutes
CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium
The FDA has determined that the known and potential benefits of the vaccine for the prevention of Covid-19 outweigh the known and potential risks for individuals 18 years of age and older for whom other authorized or approved vaccines are not accessible
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment
Subscribe To Our Newsletter & Stay Updated
